AB120923
Leelamine, Pyruvate dehydrogenase kinase (PDK) inhibitor
Be the first to review this product! Submit a review
|
(0 Publication)
MW 285.47 g/mol, Purity >98%. Pyruvate dehydrogenase kinase (PDK) inhibitor (IC50 = 9.5 μM). It has weak affinity for human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 μM.
1 Images
- Chemical Structure
Lab
Chemical Structure - Leelamine, Pyruvate dehydrogenase kinase (PDK) inhibitor (AB120923)
2D chemical structure image of ab120923, Leelamine, Pyruvate dehydrogenase kinase (PDK) inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Product protocols
For this product, it's our understanding that no specific protocols are required. You can visit:
- Visit the General protocols
- Visit the Troubleshooting
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com